Avonza

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

Avonza is a fixed-dose combination antiretroviral tablet used for the treatment of HIV-1-infectie. Each tablet contains three active ingredients — Lamivudine 300mg, Tenofovir Disoproxil Fumarate 300mg, en Efavirenz 600mg — combined into a single daily pill. As a generic equivalent of Atripla, Avonza delivers the same triple-drug regimen at a fraction of the cost, making effective HIV treatment more accessible worldwide.

When you buy Avonza online from MedsBase, you receive genuine, WHO-prequalified antiretroviral tablets manufactured under strict Good Manufacturing Practice (GMP) standards, shipped with discreet packaging and worldwide delivery. Browse our full range of HIV medications for additional antiretroviral options.

Avonza Product Overview

Avonza belongs to a class of medicines known as complete single-tablet regimens (STRs) for HIV-1. It combines two nucleoside reverse transcriptase inhibitors (NRTIs) with one non-nucleoside reverse transcriptase inhibitor (NNRTI), providing a complete antiretroviral therapy in one convenient tablet taken once daily.

Avonza simplifies HIV-behandeling by replacing what would otherwise be three separate medications into a single pill, improving adherence and reducing the complexity of daily antiretroviral therapy.

How Avonza Works

The Avonza tablet contains three antiretroviral agents that target HIV-1 at different stages of its replication cycle. By attacking the virus through multiple mechanisms simultaneously, Avonza suppresses viral load more effectively and reduces the risk of drug resistance.

Lamivudine (300mg) — Nucleoside Reverse Transcriptase Inhibitor (NRTI)

Lamivudine (also known as 3TC) is a synthetic nucleoside analogue. Once inside an HIV-infected cell, it is phosphorylated to its active triphosphate form, which competes with the natural nucleoside deoxycytidine triphosphate. When incorporated into the growing viral DNA chain by reverse transcriptase, it causes chain termination — blocking further DNA synthesis and preventing the virus from replicating its genetic material.

Tenofovir Disoproxil Fumarate (300mg) — Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Tenofovir is a nucleotide analogue that, like Lamivudine, inhibits HIV reverse transcriptase. However, because it is already a nucleotide (monophosphate), it requires one fewer phosphorylation step to become active. Tenofovir diphosphate competes with deoxyadenosine triphosphate and, when incorporated into viral DNA, causes obligate chain termination. Its distinct resistance profile complements Lamivudine, providing a robust NRTI backbone.

Efavirenz (600mg) — Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Efavirenz works through a different mechanism from the two NRTIs. Rather than being incorporated into the DNA chain, it binds directly to HIV-1 reverse transcriptase at a site away from the active site (an allosteric site), causing a conformational change that disrupts the enzyme’s function. This non-competitive inhibition effectively shuts down viral DNA synthesis through an entirely separate pathway.

Triple-Action Synergy

Together, these three components create a powerful barrier to HIV replication. The dual NRTI backbone (Lamivudine + Tenofovir) blocks reverse transcription through chain termination, while Efavirenz disables the same enzyme through allosteric inhibition. This multi-target approach is central to modern antiretroviral therapy — it suppresses the virus more completely and makes it significantly harder for HIV to develop resistance mutations against all three drugs simultaneously.

Toepassingen en Indicaties

Avonza is indicated for the treatment of HIV-1-infectie as a complete regimen in the following patient populations:

• Adults — treatment-naïve patients starting antiretroviral therapy for the first time, or patients switching from a stable regimen with undetectable viral load
• Adolescents weighing ≥40kg — who can swallow the tablet whole and require a complete single-tablet regimen

Important limitations:

• Avonza is not indicated for pre-exposure prophylaxis (PrEP) — Efavirenz is not appropriate for HIV prevention in uninfected individuals
• Avonza is not effective against HIV-2 — Efavirenz has no activity against HIV-2 reverse transcriptase
• Avonza should not be used as monotherapy or co-administered with other products containing the same active ingredients (e.g., separate Lamivudine, Tenofovir, or Efavirenz tablets)

Avonza Dosage

The recommended dose of Avonza is one tablet taken once daily, on an empty stomach. Dosing at bedtime is strongly recommended to minimize central nervous system (CNS) side effects associated with Efavirenz, such as dizziness and vivid dreams.

• Timing: Take at bedtime, preferably 2–3 hours after the last meal
• Food: Take on an empty stomach — taking with food (especially high-fat meals) increases Efavirenz absorption by up to 50%, which may worsen side effects
• Swallow whole: Do not crush, break, or chew the tablet
• Consistency: Take at the same time every day to maintain steady drug levels
• Gemiste dosis: If you miss a dose, take it as soon as you remember unless it is almost time for the next dose — do not double up

No dose adjustment is needed for patients with mild renal impairment (creatinine clearance ≥50 mL/min). Avonza should not be used in patients with moderate or severe renal impairment, as the Tenofovir component requires dose adjustment that cannot be achieved with a fixed-dose combination.

Benefits of a Single-Pill Regimen

Taking a single tablet daily instead of multiple pills offers significant advantages for long-term HIV management:

• Improved adherence — simpler regimens lead to better medication-taking behaviour, which is critical for maintaining viral suppression
• Reduced pill burden — one tablet replaces three separate medications, reducing the daily reminder of living with HIV
• Lower risk of resistance — better adherence means fewer missed doses, which reduces the chance of the virus developing drug-resistant mutations
• Convenience — easier to incorporate into a daily routine, especially for patients managing other health conditions
• Kosteneffectief — as a generic equivalent of Atripla, Avonza provides the same proven triple-drug combination at significantly lower cost
• Discreet — a single tablet is easier to store and take discreetly compared to multiple pill bottles

Avonza Side Effects

Like all antiretroviral medications, Avonza can cause side effects. Most are mild to moderate and tend to improve within the first 2–4 weeks of treatment. The Efavirenz component is responsible for the majority of early side effects, particularly those affecting the central nervous system.

Veelvoorkomende bijwerkingen

CNS side effects from Efavirenz — particularly dizziness and vivid dreams — are very common during the first 1–2 weeks but typically resolve within 2–4 weeks of continued use. Taking the tablet at bedtime significantly reduces the impact of these effects on daily activities.

Ernstige bijwerkingen (zeldzaam)

Seek immediate medical attention if you experience any of the following:

• Lactic acidosis — symptoms include unusual muscle pain, difficulty breathing, stomach pain with nausea/vomiting, cold or blue skin, and dizziness. This is a rare but potentially life-threatening complication of NRTIs (Lamivudine and Tenofovir).
• Hepatotoxiciteit — severe liver damage presenting as jaundice (yellowing of skin or eyes), dark urine, pale stools, or persistent abdominal pain
• Hepatitis B flare — patients co-infected with Hepatitis B may experience severe acute exacerbations of hepatitis if Avonza is discontinued (see Warnings section below)
• Severe skin reactions — Stevens-Johnson syndrome (SJS) has been reported rarely with Efavirenz. Discontinue immediately if blistering or mucosal lesions develop.
• Psychiatric symptoms — severe depression, suicidal thoughts, or psychosis (uncommon but reported with Efavirenz)
• Nierfunctiestoornis — Tenofovir can affect kidney function, particularly proximal renal tubular function (Fanconi syndrome)

Important Warnings and Precautions

Before starting Avonza HIV treatment, your healthcare provider should evaluate several important factors:

• Test for Hepatitis B before starting treatment — Lamivudine and Tenofovir are both active against Hepatitis B virus (HBV). If Avonza is stopped in a co-infected patient, the sudden removal of HBV suppression can trigger a severe hepatitis B flare. Monitor liver function closely for at least several months after discontinuation.
• Renal function monitoring — Tenofovir Disoproxil Fumarate can cause nephrotoxicity, including Fanconi syndrome and acute renal failure. Check serum creatinine and estimated creatinine clearance before starting therapy and at regular intervals during treatment. Avoid co-administration with other nephrotoxic agents.
• Bone density monitoring — Tenofovir has been associated with decreases in bone mineral density (BMD). Consider monitoring in patients with a history of pathologic fracture or at risk for osteoporosis. Calcium and vitamin D supplementation may be beneficial.
• CNS effects — Efavirenz causes neuropsychiatric side effects in many patients. These usually resolve within 2–4 weeks but can persist in some individuals. Avoid driving or operating heavy machinery until you know how the medication affects you. Patients with a history of psychiatric disorders should be monitored closely.
• Zwangerschap — Efavirenz was previously associated with neural tube defects in animal studies. While more recent human data are reassuring, discuss the risks and benefits with your healthcare provider if you are pregnant or planning pregnancy.
• Immune reconstitution syndrome — when antiretroviral therapy is initiated, the recovering immune system may produce an inflammatory response to pre-existing infections (e.g., MAC, CMV, TB). This is not a reason to stop treatment.

Geneesmiddelinteracties

Efavirenz is a moderate inducer of CYP3A4 and an inhibitor and inducer of CYP2B6, which means it can significantly alter the blood levels of many other medications. Lamivudine and Tenofovir have fewer drug interactions but should still be reviewed.

Contraindicated combinations (do NOT use with Avonza):

• Voriconazol — Efavirenz significantly reduces voriconazole levels while voriconazole increases Efavirenz levels, creating a dangerous interaction in both directions
• St. John’s wort (Hypericum perforatum) — a potent CYP3A4 inducer that can dramatically reduce Efavirenz levels, leading to loss of virologic response and possible resistance
• Elbasvir/grazoprevir — Efavirenz significantly reduces levels of these hepatitis C antivirals

Use with caution (dose adjustments may be needed):

• Rifampicine — may require Efavirenz dose adjustment (often increased to 800mg); consult specialist guidance for TB/HIV co-treatment
• Hormonale anticonceptiva — Efavirenz may reduce the effectiveness of oral contraceptives; use additional or alternative contraception
• Warfarine — plasma levels may be affected; monitor INR closely
• Statins metabolised by CYP3A4 (e.g., atorvastatin, simvastatin) — dose adjustments may be required
• Methadon — Efavirenz reduces methadone levels; patients may require methadone dose increases

Always provide your healthcare provider with a complete list of all medications, supplements, and herbal products you are taking before starting Avonza.

Frequently Asked Questions About Avonza

Can I take Avonza with food?

Avonza should be taken on an lege maag, ideally at bedtime. Taking it with food — particularly high-fat meals — can increase absorption of Efavirenz by up to 50%, which may intensify side effects such as dizziness and vivid dreams. Wait at least 2 hours after your last meal before taking your dose.

What should I do if I miss a dose of Avonza?

Take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed one. Consistent daily dosing is essential for maintaining viral suppression and preventing drug resistance.

How long does it take for Avonza to suppress the virus?

Most patients on an Efavirenz-based regimen like Avonza achieve an undetectable viral load within 12–24 weeks of starting treatment, provided they maintain consistent daily adherence. Your healthcare provider will monitor your viral load through regular blood tests to confirm virologic suppression.

Can I switch to Avonza from Atripla?

Yes. Avonza contains the same three active ingredients in the same doses as Atripla (Efavirenz 600mg / Emtricitabine is replaced by Lamivudine 300mg / Tenofovir DF 300mg). The key difference is that Avonza uses Lamivudine instead of Emtricitabine. Since Lamivudine and Emtricitabine are pharmacologically very similar (both are cytidine analogues with near-identical resistance profiles), switching is generally straightforward under medical supervision. Consult your HIV specialist before making any changes to your regimen.

Will the dizziness and vivid dreams go away?

Yes, for most patients. The CNS side effects caused by Efavirenz — including dizziness, vivid dreams, difficulty concentrating, and insomnia — are most pronounced during the first 1–2 weeks and typically resolve within 2–4 weeks of continued treatment. Taking your dose at bedtime helps minimize their impact on your daily life. If these effects persist beyond 4 weeks or become severe, speak with your healthcare provider.

Is Avonza safe during pregnancy?

Efavirenz was historically classified as FDA Pregnancy Category D due to neural tube defects observed in animal studies. However, more recent human data from large observational studies have not confirmed a significantly increased risk. Current WHO guidelines include Efavirenz-based regimens as acceptable options during pregnancy. Nevertheless, discuss the risks and benefits with your healthcare provider, who may recommend alternative regimens depending on your individual circumstances.

Can Avonza cure HIV?

Nee. Avonza is not a cure for HIV. It is an antiretroviral medication that suppresses viral replication to undetectable levels when taken consistently. This protects the immune system, prevents progression to AIDS, and dramatically reduces the risk of transmitting HIV to others (treatment as prevention). However, if Avonza is stopped, the virus will rebound. Lifelong treatment is currently required.

Do I need regular blood tests while taking Avonza?

Yes. Your healthcare provider should monitor several parameters regularly, including HIV viral load, CD4 cell count, renal function (serum creatinine, estimated GFR), liver function tests, en Hepatitis B status (if co-infected). Bone mineral density may also be monitored in patients at risk. These tests ensure the medication is working effectively and detect any adverse effects early.

Disclaimer

The information provided on this page is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding HIV treatment or any medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. MedsBase does not provide medical consultations or prescribe medications. Use of Avonza or any antiretroviral medication should be under the supervision and guidance of a qualified healthcare professional.

Veelgestelde vragen

How does Avonza work?

Avonza is an antiretroviral that suppresses HIV replication; it is used as part of a multi-drug combination regimen, never as monotherapy. The mechanism, dose-by-indication tables, and contraindication list above give the molecule-specific clinical detail.

How quickly does Avonza work?

De onderdrukking van de virale load is geleidelijk; significante dalingen worden meestal gezien binnen 4–12 weken van consistent gebruik. Lees het indicatiespecifieke doseringsgedeelte hierboven voor het schema dat op uw geval van toepassing is.

Wat zijn de meest voorkomende bijwerkingen?

Het bijwerkingsprofiel hangt af van het molecuul en de dosering. Het klinische gedeelte hierboven vermeldt de frequente, occasionele en zeldzame bijwerkingen die te verwachten zijn, plus de waarschuwingssignalen die direct medisch onderzoek vereisen.

Can I take Avonza with food or alcohol?

Interacties met voedsel en alcohol variëren per molecuul. Raadpleeg de interactietabel hierboven voor de specifieke regels met betrekking tot voedsel, alcohol en gelijktijdige medicatie die van toepassing zijn.

Wat moet ik doen als ik een dosis heb gemist?

Over het algemeen kunt u een gemiste dosis innemen zodra u eraan denkt, tenzij het bijna tijd is voor de volgende geplande dosis, in dat geval slaat u deze over — verdubbel nooit de dosis. Specifieke moleculen hebben specifieke regels; de doseringssectie hierboven vermeldt of dit medicatie niet-standaard regels heeft voor gemiste doses.

Where can I order Avonza from MedsBase?

MedsBase ships Avonza discreetly worldwide from a WHO-GMP certified manufacturer. Card payments are processed through a regulated crypto on-ramp — your bank statement shows the processor name (a regulated card-payment processor), never “MedsBase” or any medication name. Every order is covered by our 20-business-day Reshipment Assurance.

Those prescribed Avonza (TDF/lamivudine/efavirenz) for HIV treatment who enquire about prophylaxis options for HIV-negative partners can be directed to Tenvir EM (tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg), the dual NRTI backbone approved for oral HIV pre-exposure prophylaxis.

Gerelateerde alternatieven

Andere producten in Chronische aandoeningen die klanten ook bekijken:

• Encorate
• Tamodex
• Cotrip
• Seroflo Inhaler
• Hisone

Meer opties in HIV-medicatie

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Tavin EM

US$22.00 – US$114.00Preisspanne: US$22.00 bis US$114.00

Ricovir EM

US$24.90 – US$120.00Preisspanne: US$24.90 bis US$120.00

Isentress

US$170.00 – US$480.00Preisspanne: US$170.00 bis US$480.00

Tenvir Em

US$34.00 – US$168.00Preisspanne: US$34.00 bis US$168.00